Dent Clin North Am. 2005 Apr;49(2):309-26.

Salivary hypofunction and xerostomia: diagnosis and treatment.

Source

Comprehensive Care and Therapeutics, University of Maryland Dental School, 666 West Baltimore Street, 3E-32, Baltimore, MD 21201-1586, USA. jatkinso@mail.nih.gov

Abstract

Salivary gland hypofunction and complaints of xerostomia are common in elderly patients, irrespective of their living situation. Medication use is frequently related to dry mouth symptoms and reductions in salivary flow rates. Patients with reduced salivary flow are at increased risk for caries, oral fungal infections, swallowing problems, and diminished or altered taste. Oral health care providers should institute aggressive preventive measures and recommend palliative care for patients with significant reduction in salivary gland function. The systemic agents pilocarpine and cevimeline may help selected patients. Selective use of fluoride-releasing restorative materials and conservative treatment plans are recommended for this patient group.

PMID:: 15755407; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Molecular Biology Databases

Supplemental Content

Related citations

The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study. [Clin Rheumatol. 2008]
The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
Leung KC, McMillan AS, Wong MC, Leung WK, Mok MY, Lau CS. Clin Rheumatol. 2008 Apr; 27(4):429-36. Epub 2007 Sep 26.
A new medication for treatment of dry mouth in Sjögren's syndrome. [Tex Dent J. 2001]
A new medication for treatment of dry mouth in Sjögren's syndrome.
al-Hashimi I, Taylor SE. Tex Dent J. 2001 Apr; 118(3):262-6.
Efficacy prediction of cevimeline in patients with Sjögren's syndrome. [Clin Rheumatol. 2007]
Efficacy prediction of cevimeline in patients with Sjögren's syndrome.
Yamada H, Nakagawa Y, Wakamatsu E, Sumida T, Yamachika S, Nomura Y, Mishima K, Saito I. Clin Rheumatol. 2007 Aug; 26(8):1320-7. Epub 2007 Jan 13.
Review Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management. [Drugs Aging. 2005]
Review Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
Al-Hashimi I. Drugs Aging. 2005; 22(11):887-99.
Review Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. [Support Care Cancer. 2003]
Review Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
Nieuw Amerongen AV, Veerman EC. Support Care Cancer. 2003 Apr; 11(4):226-31. Epub 2002 Oct 22.

See reviews... See all...

Cited by 2 PubMed Central articles

Geriatric restorative care - the need, the demand and the challenges. [J Conserv Dent. 2011]
Geriatric restorative care - the need, the demand and the challenges.
Nadig RR, Usha G, Kumar V, Rao R, Bugalia A. J Conserv Dent. 2011 Jul; 14(3):208-14.
Review Oral graft-versus-host disease. [Oral Dis. 2008]
Review Oral graft-versus-host disease.
Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC. Oral Dis. 2008 Jul; 14(5):396-412.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Salivary hypofunction and xerostomia: diagnosis and treatment.
Salivary hypofunction and xerostomia: diagnosis and treatment.
Dent Clin North Am. 2005 Apr ;49(2):309-26.

PubMed
Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed m...
Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).
J Virol. 2000 Oct ;74(20):9771-5.

PubMed
Multiple types of dieting prospectively predict weight gain during the freshman ...
Multiple types of dieting prospectively predict weight gain during the freshman year of college.
Appetite. 2006 Jul ;47(1):83-90. Epub 2006 May 2 .

PubMed
Oral and oral pharyngeal cancer: an update on incidence and epidemiology, identi...
Oral and oral pharyngeal cancer: an update on incidence and epidemiology, identification, advances in treatment, and outcomes.
Compend Contin Educ Dent. 2002 Dec ;23(12 Suppl):25-9.

PubMed
Plasma cell balanitis: clinicopathologic study of 112 cases and treatment modali...
Plasma cell balanitis: clinicopathologic study of 112 cases and treatment modalities.
J Cutan Med Surg. 2006 Jan-Feb ;10(1):11-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Salivary hypofunction and xerostomia: diagnosis and treatment.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information